These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15648301)

  • 21. Heart rate lowering by inhibition of the pacemaker current: a new therapeutic perspective in cardiovascular disease.
    Dilaveris P; Giannopoulos G; Synetos A; Gatzoulis K; Stefanadis C
    Cardiovasc Hematol Agents Med Chem; 2006 Oct; 4(4):313-8. PubMed ID: 17073608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of the pacemaker current: a bradycardic therapy for off-pump coronary operations.
    Bel A; Perrault LP; Faris B; Mouas C; Vilaine JP; Menasché P
    Ann Thorac Surg; 1998 Jul; 66(1):148-52. PubMed ID: 9692455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-ischemic effects of ivabradine, a selective heart rate-reducing agent, in exercise-induced myocardial ischemia in pigs.
    Vilaine JP; Bidouard JP; Lesage L; Reure H; Péglion JL
    J Cardiovasc Pharmacol; 2003 Nov; 42(5):688-96. PubMed ID: 14576519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in the management of heart failure: the role of ivabradine.
    Müller-Werdan U; Stöckl G; Werdan K
    Vasc Health Risk Manag; 2016; 12():453-470. PubMed ID: 27895488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preserved Autonomic Cardiovascular Regulation With Cardiac Pacemaker Inhibition: A Crossover Trial Using High-Fidelity Cardiovascular Phenotyping.
    Heusser K; Tank J; Brinkmann J; Schroeder C; May M; Großhennig A; Wenzel D; Diedrich A; Sweep FC; Mehling H; Luft FC; Jordan J
    J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26764413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defying the economists: a decrease in heart rate improves not only cardiac but also endothelial function.
    Triggle CR
    Br J Pharmacol; 2008 Jun; 154(4):727-8. PubMed ID: 18438420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specific inhibition of HCN channels slows rhythm differently in atria, ventricle and outflow tract and stabilizes conduction in the anoxic-reoxygenated embryonic heart model.
    Sarre A; Pedretti S; Gardier S; Raddatz E
    Pharmacol Res; 2010 Jan; 61(1):85-91. PubMed ID: 19818405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardioprotection by ivabradine through heart rate reduction and beyond.
    Heusch G; Skyschally A; Schulz R
    J Cardiovasc Pharmacol Ther; 2011; 16(3-4):281-4. PubMed ID: 21821529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversing dobutamine-induced tachycardia using ivabradine increases stroke volume with neutral effect on cardiac energetics in left ventricular post-ischaemia dysfunction.
    Bakkehaug JP; Naesheim T; Torgersen Engstad E; Kildal AB; Myrmel T; How OJ
    Acta Physiol (Oxf); 2016 Oct; 218(2):78-88. PubMed ID: 27145482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Properties of ivabradine-induced block of HCN1 and HCN4 pacemaker channels.
    Bucchi A; Tognati A; Milanesi R; Baruscotti M; DiFrancesco D
    J Physiol; 2006 Apr; 572(Pt 2):335-46. PubMed ID: 16484306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardioprotective effects of the Ιf current inhibition by ivabradine during cardiac dysfunction.
    Su JB
    Curr Pharm Biotechnol; 2014; 14(14):1213-9. PubMed ID: 24831809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heart rate reduction: a potential target for the treatment of myocardial ischaemia.
    Danchin N; Aly S
    Therapie; 2004; 59(5):511-5. PubMed ID: 15648303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure.
    Mulder P; Barbier S; Chagraoui A; Richard V; Henry JP; Lallemand F; Renet S; Lerebours G; Mahlberg-Gaudin F; Thuillez C
    Circulation; 2004 Apr; 109(13):1674-9. PubMed ID: 14981003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Review of the If selective channel inhibitor ivabradine in the treatment of chronic stable angina.
    Prasad UK; Gray D; Purcell H
    Adv Ther; 2009 Feb; 26(2):127-37. PubMed ID: 19259630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use-dependent blockade of cardiac pacemaker current (If) by cilobradine and zatebradine.
    Van Bogaert PP; Pittoors F
    Eur J Pharmacol; 2003 Oct; 478(2-3):161-71. PubMed ID: 14575801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Investigation of pacemaker shift in the rabbit sinoatrial node using the optical mapping technique].
    Abramochkin DV; Kuz'min VS; Sukhova GS; Rozenshtraukh LV
    Biofizika; 2010; 55(3):500-6. PubMed ID: 20586331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ivabradine: an intelligent drug for the treatment of ischemic heart disease.
    Riccioni G
    Molecules; 2012 Nov; 17(11):13592-604. PubMed ID: 23159921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heart rate reduction with ivabradine improves energy metabolism and mechanical function of isolated ischaemic rabbit heart.
    Ceconi C; Cargnoni A; Francolini G; Parinello G; Ferrari R
    Cardiovasc Res; 2009 Oct; 84(1):72-82. PubMed ID: 19477966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ivabradine: Cardioprotection By and Beyond Heart Rate Reduction.
    Heusch G; Kleinbongard P
    Drugs; 2016 May; 76(7):733-40. PubMed ID: 27041289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ivabradine: from molecular basis to clinical effectiveness.
    Riccioni G
    Adv Ther; 2010 Mar; 27(3):160-7. PubMed ID: 20419486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.